RareCyte

RareCyte is a well-funded life science company focused on the development of unique technology to detect and characterize rare cells in blood. Our technology platform has been adopted by leading research institutions and pharmaceutical companies world-wide for research and clinical programs. The RareCyte platform has the potential to become the leading diagnostic tool in oncology, prenatal diagnostics, infectious disease and immunology.